• Home
  • Resources
  • Colloquium

Spring 2018

All seminars take place on Mondays from 4:00 pm - 5:00 pm in LEEP2 2420, unless otherwise specified.

January 22nd: 

4:00pm in LEEP2 2420

Speaker:  Steve Gehrke, PhD

New Spring 2018 students only

Colloquium review


February 5th:

Speaker:  Sara Wilson, PhD

Low back pain and low back injuries are common workplace injuries. In this presentation, Dr. Wilson will discuss the approach she and members of her laboratory have taken to use control theory to understand the etiology of these injuries. In particular, she will discuss the roles of occupational exposures, such as vibration, as well as subjects specific characteristics, like coordination patterns, in the dynamics of the lumbar spine.


February 12th: KU Environment, Health & Safety

Speaker:  Mike Russell

What you need to know about Environment, Health, & Safety at KU


March 5th: Polymeric Micelles for Delivery of Gaseous Signal-Transmitter Molecules        

Speaker:  Urara Hasegawa, PhD

Assistant Professor // Department of Chemical Engineering, Kansas State University // hasegawa@ksu.edu

Gaseous signal-transmitter molecules such as nitric oxide (NO), carbon monoxide (CO) and hydrogen sulfide (H2S) have recently emerged as therapeutic gases with potential applications in treatment of various pathological conditions like cancer and cardiovascular diseases. Despite their interesting biological functions, the therapeutic potential of these gases has not been well explored due to the difficulty in handling of these gases. One common approach is to use small compounds (gas donors) that release gases under physiologically relevant conditions. However, most of gas donors reported so far show relatively fast gas release, which is not desirable for therapeutic applications that require sustained gas release. Another drawback is that small gas donors and/or their decomposition byproducts often show side effects, which blur the real biological activities of therapeutic gases.

To address the issues associated with the small gas donors, we have developed polymeric micelle-based gas donors. These gas donor micelles enable controlled release of gases within cells, inhibit toxic side effects and exhibit much higher biological activities in different cells compared to the corresponding small gas donors. In this talk, the design, synthesis and characterization of the block copolymer micelles as well as their biological evaluation in cell culture and the chick chorioallantoic membrane (CAM) assay will be presented to highlight the potential applications of the gas donor micelles in wound healing and cancer therapy.


March 26th:         

Speaker:  Yong Huang, PhD

- "Dr. Huang's research interests center around the processing of biological and engineering materials for healthcare/energy applications and the understanding of process-induced damage or defect structures. His current research program covers three main topics: 1) 3D direct writing of biological and engineering materials with a goal to layer-by-layer fabricate scaffold-free human tissues/organs as well as 3D engineering structures using laser- and inkjet-based techniques; 2) precision machining and performance evaluation of machined medical implants with a goal to machine and characterize engineering materials, especially for medical implant applications; and 3) fabrication of polymeric microspheres / microcapsules / hollow fiber membranes with a goal to fabricate functional constructs/structures from polymeric materials."

“Dr. Huang's Profile.” Dr. Yong Huang | Center for Manufacturing Innovation, mtrc.mae.ufl.edu/huang.php.


April 2nd:         

Speaker:  Ryan Hansen, PhD



April 16th: Preparation for PhD Qualifying Exam

All students taking the exam in 2018 should attend. All others are optional.


April 23rd: Professors As “Entrepreneurs” And Related Ethics Considerations/Questions​

Speaker:  Val Stella, PhD

Valentino Stella is a Distinguished Professor Emeritus at the University of Kansas with a BPharm from the Victorian College of Pharmacy, now Monash University, and his PhD from the University of Kansas in 1971. He is internationally recognized for his research involving novel ways of formulating and delivering problematic drug candidates, especially those used to treat cancer and AIDs. He is the inventor or co-inventor of the approved drugs fosphenytoin (Cerebyx®), Viread®, Lusedra®, the formulation covering Velcade®, and Captisol®, the solubilizer used in the injectable forms of Vfend®, Geodon®, Abilify®, Nexterone®, Kyprolis (carfilzomib)®, Noxafil-IV® and Cerenia. His many honors include the American Pharmacists Association’s Takeru Higuchi Research Prize, Distinguished Scientist award from the American Association of Pharmaceutical Scientists and is a Fellow of the AAAS and the National Academy of Inventors. Stella has more than 300 publications, reviews and book chapters.  He holds 45 issued U.S. Patents and many foreign patents.


April 30th: Can Engineers Read Minds?

Speaker:  Dave Thompson, PhD